SCHEMBL25239396

SCHEMBL25239396

Clc1cc(Br)c2[nH]nc(I)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31347094 0.79 DYRK1A (0.39) —
SCHEMBL26108747 0.79 DYRK1A (0.39) —
SCHEMBL26105260 0.75 — —
SCHEMBL31347131 0.75 — —
SCHEMBL26104190 0.72 MAPT (0.38) —
SCHEMBL30612183 0.72 MAPT (0.38) —
SCHEMBL19743468 0.72 LMNA (0.38) —
SCHEMBL26107697 0.67 ALPL (0.40) —
SCHEMBL19958260 0.64 DYRK1A (0.32) —
SCHEMBL31206714 0.64 CHEK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116865-A1 PYRAZOLE-CONTAINING DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 优领医药科技(上海)有限公司 2023-06-29 — — WO disclosed
WO-2023116865-A1 PYRAZOLE-CONTAINING DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 优领医药科技(上海)有限公司 2023-06-29 — — WO disclosed
Send feedback